SCHEMBL16236142

SCHEMBL16236142

CCOC(=O)Sc1cccc2cccc(SC(=O)N(CC)CC)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
HSD17B10 Q99714 4/20 0.53
HPGD P15428 4/20 0.53
KDM4E B2RXH2 4/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 3/20 0.37
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ACHE P22303 1/20 0.36
CYP1A2 P05177 1/20 0.36
CDC25B P30305 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
POLB P06746 2/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16239185 0.89 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL16235879 0.89 ALDH1A1 (0.64) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL16235702 0.82 LMNA (0.43) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL16236256 0.82 HSD17B10 (0.49) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL17628542 0.79 POLB (0.53) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL16235753 0.78 ALDH1A1 (0.53) ALDH1A1HSD17B10HPGDKDM4EHTT
SCHEMBL16235966 0.78 NPC1 (0.43) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL16236033 0.77 HSD17B10 (0.52) ALDH1A1HSD17B10HPGDTSHRMEN1
SCHEMBL16239303 0.76 TYMS (0.41) ALDH1A1HSD17B10HPGDKDM4ETP53
SCHEMBL18113265 0.74 TSHR (0.59) ALDH1A1HSD17B10HPGDKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005860-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2018-06-26 US disclosed
EP-2997049-B1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA SRL (IT) 2017-08-23 EP disclosed
US-20170166667-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-06-15 US disclosed
US-9644051-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-05-09 US disclosed
US-20160090428-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia, s.r.l. (IT) 2016-03-31 US disclosed
EP-2997049-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2016-03-23 EP disclosed
WO-2014184289-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2014-11-20 WO disclosed
EP-2803679-A1 Catalyst components for the polymerization of olefins Basell Poliolefine Italia S.r.l. (IT) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005860-B2 Catalyst components for the polymerization of olefins OXER1, OXSR1, NR0B2 ALDH1A1 2092/4885HSD17B10 1221/4885HPGD 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.